生理氧条件提高造血干细胞扩增培养的选择性
该研究显示,采用生理氧条件的聚乙烯醇(PVA)小鼠造血干细胞(HSC)培养可提高选择性,单细胞转录组分析证实生理氧培养抑制了定向祖细胞;长期生理氧扩增可从全骨髓、脾和胚胎组织中进行体外HSC选择,且HSC选择性体外培养可清除引起移植物抗宿主病(GVHD)的T细胞,并可与无基因毒性抗体为基础的预处理HSCT方案联合。
要点
- 生理氧条件可提高PVA为基础的小鼠HSC培养的选择性。
- 单细胞转录组分析证实生理氧培养抑制定向祖细胞。
- HSC选择性体外培养可清除引起GVHD的T细胞。
核心结论
- 生理氧条件提供了一种改善PVA为基础HSC培养的简单方法,并揭示了其分子表型,突显了选择性HSC扩增系统对异基因HSCT的潜在转化意义。
研究设计与样本
- 研究采用小鼠HSC培养并结合单细胞转录组分析,比较生理氧与常规氧条件对PVA为基础培养选择性的影响。
主要发现
- 生理氧培养条件可提高PVA为基础的小鼠HSC培养的选择性。
- 单细胞转录组分析证实生理氧培养抑制了定向祖细胞。
- 长期生理氧扩增可从全骨髓、脾和胚胎组织中进行基于体外培养的HSC选择。
- HSC选择性体外培养可清除引起GVHD的T细胞,且该方法可与无基因毒性抗体为基础的预处理HSCT方案联合。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hematopoietic stem cells (HSCs) are a rare type of hematopoietic cell that can entirely reconstitute the blood and immune system after transplantation. Allogeneic HSC transplantation (HSCT) is used clinically as a curative therapy for a range of hematolymphoid diseases; however, it remains a high-risk therapy because of its potential side effects, including poor graft function and graft-versus-host disease (GVHD). Ex vivo HSC expansion has been suggested as an approach to improve hematopoietic reconstitution in low-cell dose grafts. Here, we demonstrate that the selectivity of polyvinyl alcohol (PVA)-based mouse HSC cultures can be improved using physioxic culture conditions. Single-cell transcriptomic analysis helped confirm the inhibition of lineage-committed progenitor cells in physioxic cultures. Long-term physioxic expansion also afforded culture-based ex vivo HSC selection from whole bone marrow, spleen, and embryonic tissues. Furthermore, we provide evidence that HSC-selective ex vivo cultures deplete GVHD-causing T cells and that this approach can be combined with genotoxic-free antibody-based conditioning HSCT approaches. Our results offer a simple approach to improve PVA-based HSC cultures and the underlying molecular phenotype, and highlight the potential translational implications of selective HSC expansion systems for allogeneic HSCT.
引用
- Igarashi KJ, Kucinski I, Chan YY, et al. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures. Blood Adv. 2023. PMID: 36809781. doi:10.1182/bloodadvances.2023009668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。